Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by
Infinium Global Research on anatomic pathology testing market provides in-depth
analysis of segments and sub-segments in the global as well as regional
anatomic pathology testing market. The study also highlights the impact of
drivers, restraints, and macro indicators on the global and regional anatomic
pathology testing market over the short term as well as long term. The report
is a comprehensive presentation of trends, forecasts, and dollar values of the global
anatomic pathology testing market. According to the report, the global anatomic
pathology testing market is projected to grow at a CAGR of 5.61% over the
forecast period of 2020-2026.
Anatomic pathology is a branch of
science or medicine that predominantly involves a microscopic, biochemical, and
molecular examination of organs and tissues to find out the efficiency of
diseases. The main objective of anatomic pathology is to identify aberrations
in order to manage diagnosis and treatment. It helps to detect numerous types
of tumors and cancer. It is also sometimes useful to assess liver and kidney
diseases efficiently. Anatomic pathology testing is a super-specialty test. To
accomplish this type of test, a person should have a qualified certification
from a recognized body, for instance, the American Board of Pathology or the
American Osteopathic Board of Pathology. Like clinical pathology reports,
anatomic pathology reports also comprise important elements such as name,
number, sample type, and source. Numerous anatomic pathology departments
operate according to the particular need of a patient.
An increase in the clinical usage
of biomarkers allows pathologists to determine disease pathogenesis at a
molecular level and guides in clinical decision-making, thereby enlightening
patient outcomes. Rising reliance on biomarkers-based pathology tests and
processes to explore common malignancy and tumorigenesis is boosting the anatomic
pathology testing market. Furthermore, high usage of advanced pathology
equipment, for example, staining systems, gross imaging, and digital
microscopes is poised to expand anatomic pathological practices to a major
extent. Moreover, digital imaging solutions provide specificity and
accuracy-related benefits over conventional techniques, which in turn, propel
the service uptake rate in the overall market. However, a lack of skilled
professionals may hinder the market growth in the near future. On the other
hand, an increasing number of clinical trials pertaining to cancer drugs
provides lucrative opportunities for the market.
Additionally, the current concern
over the spread of coronavirus is also expected to have a negative impact on
the anatomic pathology testing market. After COVID-19 was declared as an
epidemic by the WHO, countries across the world adopted nationwide lockdowns to
observe social distancing as a measure to curb the spread. This led to
limitations, disruption, challenges, and changes in each sector of every
sector. Likewise, the medical equipment & reagents sector was also impacted
by the pandemic. Hence, the limited availability of medical care for conditions
other than COVID-19 around the globe has impacted the number of medical
equipment & reagent procedures conducted worldwide in a negative manner.
Furthermore, the limited availability of healthcare staff across the globe is
another foremost factor, which has a negative effect on the anatomic pathology
testing industry.
Among the geographies, the North
America region is expected to hold the largest share in the global anatomic
pathology testing market. The industry is expected to offer huge opportunities
for market growth on account of the presence of numerous healthcare companies.
The increasing prevalence of chronic diseases, rapid upsurge in the geriatric
population, and high acceptance of personalized medicine and digital laboratory
propel the market in North America. Furthermore, the Asia Pacific region is
expected to witness high growth in the anatomic pathology testing market during
the forecast period. Increasing academic and government investment in
diagnostic research and growing awareness about the usage of anatomic pathology
tests among physicians in China, India, Japan, and East Asian countries is
projected to provide positive opportunities for the market across the region.
The report on the global anatomic
pathology testing market covers segments such as component and application. On
the basis of components, the sub-markets include instruments, consumables, and
services. On the basis of application, the sub-markets include disease
diagnosis, drug discovery & development, and other applications.
The report provides profiles of
the companies in the market such as Sakura Finetechnical Co., Ltd., Quest
Diagnostics Incorporated, Laboratory Corporation of America Holdings,
NeoGenomics Laboratories, Inc., Agilent Technologies, Danaher Corporation, Thermo
Fisher Scientific, F. Hoffmann-La Roche AG, Abbott Diagnostics, and Advanced
Cell Diagnostics.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of the anatomic pathology testing market. Moreover, the study highlights
current market trends and provides forecasts from 2020-2026. We also have highlighted
future trends in the market that will affect the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings
an insight into the market share of the leading players.
Please Choose One of them.